Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -5.37% is 1239% below its 5-year average of 0.47%, near the low end of its 5-year range (-8.60%–9.39%).
47.33% below its 12-month average of -3.64%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.64%.
RETURN ON ASSETS (ROA)
-5.37%
RETURN ON ASSETS (ROA) AVG TTM
-3.64%
RETURN ON ASSETS (ROA) AVG 3Y
-1.62%
RETURN ON ASSETS (ROA) AVG 5Y
0.47%
RETURN ON ASSETS (ROA) AVG 10Y
5.29%
RETURN ON ASSETS (ROA) AVG 15Y
5.97%
RETURN ON ASSETS (ROA) AVG 20Y
7.24%
CURRENT VS TTM AVG
-47.33%
CURRENT VS 3Y AVG
-230.46%
CURRENT VS 5Y AVG
-1238.52%
CURRENT VS 10Y AVG
-201.43%
CURRENT VS 15Y AVG
-189.91%
CURRENT VS 20Y AVG
-174.16%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-204.47%
vs the sector median at left
Baxter International Inc.
Market Cap
$12.12B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.99B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$12.56B
Return on Assets (ROA)
8.13%
TTM Avg
5.32%
3Y Avg
4.08%
5Y Avg
2.47%
Market Cap
$11.31B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
Market Cap
$11.28B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$13.17B
Return on Assets (ROA)
-3.17%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
Market Cap
$10.92B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.76B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Baxter International Inc. (BAX) | $12.12B | -5.37% | -3.64% | -1.62% | 0.47% |
| DaVita Inc. (DVA)vs › | $12.21B | 4.79% | 4.84% | 4.27% | 4.56% |
| Encompass Health Corporation (EHC)vs › | $11.99B | 8.33% | 7.48% | 6.38% | 5.99% |
| Penumbra, Inc. (PEN)vs › | $12.56B | 8.13% | 5.32% | 4.08% | 2.47% |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 7.03% | 4.83% | 6.67% | 7.46% |
| Tempus AI, Inc. (TEM)vs › | $11.28B | -10.75% | -43.49% | -42.71% | -41.26% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.17B | -3.17% | -0.94% | 2.58% | 3.75% |
| Molina Healthcare, Inc. (MOH)vs › | $10.92B | -0.04% | 5.29% | 6.08% | 6.13% |
| Align Technology, Inc. (ALGN)vs › | $10.76B | 6.44% | 6.68% | 6.69% | 12.75% |
| Universal Health Services, Inc. (UHS)vs › | $10.51B | 9.58% | 8.61% | 6.84% | 6.99% |
ROA
-5.4%
ROE
-17.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -4.77% |
| 2024-12-31 | -2.52% |
| 2023-12-31 | 9.39% |
| 2022-12-31 | -8.60% |
| 2021-12-31 | 3.83% |
| 2020-12-31 | 5.50% |
| 2019-12-31 | 5.50% |
| 2018-12-31 | 9.83% |
| 2017-12-31 | 3.52% |
| 2016-12-31 | 31.94% |
| 2015-12-31 | 4.62% |
| 2014-12-31 | 9.55% |
| 2013-12-31 | 7.98% |
| 2012-12-31 | 11.41% |
| 2011-12-31 | 11.66% |
| 2010-12-31 | 8.12% |
| 2009-12-31 | 12.71% |
| 2008-12-31 | 13.07% |
| 2007-12-31 | 11.16% |
| 2006-12-31 | 9.51% |
| 2005-12-31 | 7.51% |
| 2004-12-31 | 2.74% |
| 2003-12-31 | 6.32% |
| 2002-12-31 | 6.18% |
| 2001-12-31 | 5.92% |
| 2000-12-31 | 8.47% |
| 1999-12-31 | 8.26% |
| 1998-12-31 | 3.19% |
| 1997-12-31 | 3.45% |
| 1996-12-31 | 8.81% |
